Wat Is Daptomycin With Cas No 103060-53-3
Datomicin is a new structured cyclic lipopeptide antibiotic extracted from the fermentation broth of Streptomyces. In addition to acting on most clinically relevant gram-positive bacteria, it is more important that it has strong activity in vitro against isolated strains that have shown resistance to methicillin, vancomycin and linezolidine, This characteristic has very important clinical significance for critically infected patients.
1.Quick Details of Daptomycin
CAS:103060-53-3
Synonyms: N-[N- (1-Oxodecyl)- L-Trp-D-Asn-L-Asp-]-cyclo [L-Thr*-Gly-L-Orn-L-Asp-D-Ala-L-Asp-Gly-D-Ser- [(3R)-3-methyl-L-Glu-] -4-(2-aminophenyl)-4-oxo-L-Abu-]; N-[N-Decanoyl-L-Trp-D-Asn-L-Asp-]-cyclo[Thr*-Gly-L-Orn-L-Asp-D-Ala-L-Asp-Gly-D-Ser-[(3R)-3-methyl-L-Glu-]-3-(2-aminobenzoyl)-L-Ala-]; N-(1-OxodChemicalbookecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithinyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-α, 2-diamino-γ-oxo-benzenebutanoicacid(13-4)lactone; DAPTOMYCINE; Dapcin;Daptomycin,>=99%; DaptomycinReadyMadeSolution; Daptomycin(LY146032)
Moleculaire Formule:C72H101N17O26
Molecular Weight:1620.67
Appearance: Light yellow to yellow powder
EINECS:600-389-2
Product Categories: Organic Chemistry;Nutrition Health
2. Specification of Daptomycin
| Naam Van Het Product: | Daptomycin | Batch Nr. | JL20220811 |
| Cas | 103060-53-3 | MF Datum | Aug. 11, 2022 |
| Verpakking | 1KG/BAG | Analyse Datum | Aug. 11, 2022 |
| Hoeveelheid | 100KGS | De Vervaldatum | Aug. 10, 2024 |
| IkTEM
分析项目 |
STANDARD
技术指标 |
RESULTAAT
实测结果 |
|
| Uiterlijk | Light yellow to yellow powder | Conform | |
| Geur | Geurloos | Conform | |
| Assay | ≥95.0% | 97.9% | |
| Specific optical rotation | +15.5～+20.5 | +16.8 | |
| Clarity ofsolution | Clarified | Clarified | |
| PH | 3.0～4.5 | 3.2 | |
| Gloeirest | ≤0.2% | 0.1% | |
| Water | ≤5.0% | 2.4% | |
| Lactone hydrolysate | ≤0.80% | 0.08% | |
| β-isomer | ≤1.5% | 0.1% | |
| RS-5/6 | ≤0.80% | 0.06% | |
| RS-7 | ≤0.80% | Niet gedetecteerd | |
| RS-7a/7b | ≤0.20% | 0.07% | |
| Anhydrodaptomycin | ≤2.0% | 0.8% | |
| Other individual | ≤0.15% | Niet gedetecteerd | |
| Total impurities | ≤5.0% | 1.1% | |
| Ethyl alcohol | ≤0.5% | 0.0% | |
| Acetic acid | ≤0.5% | Niet gedetecteerd | |
| Bacterial endotoxin(EU/mg) | ≤0.28 | <0.28 | |
| Aerobic bacteria(cfu/g) | ≤1000 | <10 | |
| Mold &yeast(cfu/g) | ≤100 | <10 | |
| E.coil | Niet gedetecteerd | Niet gedetecteerd | |
| Conclusie | Gekwalificeerd | ||
3. Application of Daptomycin
Medical intermediate for the treatment of concurrent skin and skin structure infections caused by some gram-positive and sensitive strains.
4. Packing of Daptomycin
1kgs bag or requirement of clients. Keep it away from light at a temperature below 25℃.
NL 
EN 
ZH 
RU 
DE 
ES 
KO 
PT 
FR 
TH 
AR 
IT 
VI 
